Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
27.52 USD | -0.97% | +2.00% | -31.71% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-31.71% | 5.2B | |
-2.35% | 89.33B | |
+3.29% | 41.19B | |
-15.50% | 31.87B | |
+53.74% | 24.52B | |
-14.48% | 15.68B | |
-6.52% | 12.34B | |
-39.65% | 12.23B | |
+6.22% | 8.83B | |
-6.43% | 8.28B |
- Stock Market
- Equities
- BBIO Stock
- News BridgeBio Pharma, Inc.
- BridgeBio Pharma Says Initial Phase1/2 Results of Canavan Disease Therapy BBP-812 Show it is on the 'Right Track'